Q3 2010

Filed Nov 4, 2010 · 10-Q · 35 days after period end · 0001054102-10-000048

Q3 2010 · 10-Q

Revenue

$35.97M

no prior Q3 2009 on file

Net Income

-$1.67M

no prior Q3 2009 on file

EPS Diluted

-$0.11

no prior Q3 2009 on file

Gross Profit$8,483,000—

Operating Income

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 4, 2010 · 35 d after period end

Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR